Genetic polymorphisms related to the renin–angiotensin–aldosterone system and response to antihypertensive drugs

Author： Taverne Kim de Groot Mark de Boer Anthonius Klungel Olaf

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.6, Iss.4, 2010-04, pp. : 439-460

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Renin Angiotensin System Gene Polymorphisms in Response to Antihypertensive Drugs and Visit-To-Visit Blood Pressure Variability in Essential Hypertensive Patients

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 12, Iss. 4, 2014-12 ,pp. : 227-235

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs which target the renin–angiotensin–aldosterone system

By Steckelings Ulrike Muscha Paulis Ludovit Unger Thomas Bader Michael

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 4, 2011-12 ,pp. : 619-630

Informa Healthcare

Access to resources Recommend Favorite

Pleiotropic Effects of Drugs Inhibiting the Renin-Angiotensin-Aldosterone System

Current Pharmaceutical Design, Vol. 15, Iss. 5, 2009-02 ,pp. : 571-584

Bentham Science Publishers

Access to resources Recommend Favorite

Current status of renin–aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease

By Ashby Emma Louise Kehoe Patrick G

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 10, 2013-10 ,pp. : 1229-1242

Informa Healthcare

Access to resources Recommend Favorite

Role of the Renin-Angiotensin-Aldosterone System in the Pathogenesis of Atherosclerosis

Current Pharmaceutical Design, Vol. 18, Iss. 7, 2012-03 ,pp. : 981-1004

Bentham Science Publishers

Access to resources Recommend Favorite